199 related articles for article (PubMed ID: 29580198)
1. Pharmacogenetics of oral antidiabetic therapy.
Ordelheide AM; Hrabě de Angelis M; Häring HU; Staiger H
Pharmacogenomics; 2018 Apr; 19(6):577-587. PubMed ID: 29580198
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of oral antidiabetic treatment.
Schroner Z; Javorsky M; Kozarova M; Tkac I
Bratisl Lek Listy; 2011; 112(8):441-6. PubMed ID: 21863614
[TBL] [Abstract][Full Text] [Related]
3. Stratified medicine for the use of antidiabetic medication in treatment of type II diabetes and cancer: where do we go from here?
Emami-Riedmaier A; Schaeffeler E; Nies AT; Mörike K; Schwab M
J Intern Med; 2015 Feb; 277(2):235-247. PubMed ID: 25418285
[TBL] [Abstract][Full Text] [Related]
4. Prescription of oral antidiabetic drugs in Tyrol - Data from the Tyrol diabetes registry 2012-2015.
Lunger L; Melmer A; Oberaigner W; Leo M; Juchum M; Pölzl K; Gänzer J; Innerebner M; Eisendle E; Beck G; Kathrein H; Heindl B; Schönherr HR; Lechleitner M; Tilg H; Ebenbichler C
Wien Klin Wochenschr; 2017 Jan; 129(1-2):46-51. PubMed ID: 27909794
[TBL] [Abstract][Full Text] [Related]
5. A Review of the Impact of Pharmacogenetics and Metabolomics on the Efficacy of Metformin in Type 2 Diabetes.
Damanhouri ZA; Alkreathy HM; Alharbi FA; Abualhamail H; Ahmad MS
Int J Med Sci; 2023; 20(1):142-150. PubMed ID: 36619226
[TBL] [Abstract][Full Text] [Related]
6. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
7. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
Ou HT; Chang KC; Li CY; Wu JS
Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
[TBL] [Abstract][Full Text] [Related]
8. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
9. Persistence of initial oral antidiabetic treatment in patients with type 2 diabetes mellitus.
Jermendy G; Wittmann I; Nagy L; Kiss Z; Rokszin G; Abonyi-Tóth Z; Katona L; Paragh G; Karádi I; Merkely B
Med Sci Monit; 2012 Feb; 18(2):CR72-77. PubMed ID: 22293880
[TBL] [Abstract][Full Text] [Related]
10. Effect of once-daily insulin detemir on oral antidiabetic drug (OAD) use in patients with type 2 diabetes.
Vora J; Caputo S; Damci T; Orozco-Beltran D; Pan C; Svendsen AL; Sølje KS; Khunti K;
J Clin Pharm Ther; 2014 Apr; 39(2):136-43. PubMed ID: 24329524
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics and personalized treatment of type 2 diabetes.
Semiz S; Dujic T; Causevic A
Biochem Med (Zagreb); 2013; 23(2):154-71. PubMed ID: 23894862
[TBL] [Abstract][Full Text] [Related]
12. [Pitfalls and precautions concerning the use of conventional oral antidiabetic drugs].
Scheen AJ
Rev Med Liege; 2002 May; 57(5):352-6. PubMed ID: 12143186
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of Antidiabetic Drugs.
Srinivasan S; Yee SW; Giacomini KM
Adv Pharmacol; 2018; 83():361-389. PubMed ID: 29801583
[TBL] [Abstract][Full Text] [Related]
14. Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents.
Goodarzi MO; Bryer-Ash M
Diabetes Obes Metab; 2005 Nov; 7(6):654-65. PubMed ID: 16219009
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective.
Manolopoulos VG; Ragia G; Tavridou A
Pharmacogenomics; 2011 Aug; 12(8):1161-91. PubMed ID: 21843065
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacogenetics of oral antidiabetic treatment].
Tkáč I
Vnitr Lek; 2016 Mar; 62(3):186-8. PubMed ID: 27180666
[TBL] [Abstract][Full Text] [Related]
17. [Oral hypoglycemic agents and metformin in the treatment of type II non-insulin-dependent diabetes].
Isnard F
Sem Hop; 1983 Dec; 59(49):3437-8. PubMed ID: 6320423
[TBL] [Abstract][Full Text] [Related]
18. Metformin pharmacogenomics: current status and future directions.
Pawlyk AC; Giacomini KM; McKeon C; Shuldiner AR; Florez JC
Diabetes; 2014 Aug; 63(8):2590-9. PubMed ID: 25060887
[TBL] [Abstract][Full Text] [Related]
19. Genetics of type 2 diabetes mellitus and other specific types of diabetes; its role in treatment modalities.
Kota SK; Meher LK; Jammula S; Kota SK; Modi KD
Diabetes Metab Syndr; 2012; 6(1):54-8. PubMed ID: 23014256
[TBL] [Abstract][Full Text] [Related]
20. Prescription trends and the selection of initial oral antidiabetic agents for patients with newly diagnosed type 2 diabetes: a nationwide study.
Liu CH; Chen ST; Chang CH; Chuang LM; Lai MS
Public Health; 2017 Nov; 152():20-27. PubMed ID: 28719837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]